Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia
Authors:
- B. M. ShivakumarBSB. M. Shivakumar
- Sanjiban ChakrabartySCSanjiban Chakrabarty
- Harish RottiHRHarish Rotti
- Venu SeenappaVSVenu Seenappa
- Lakshmi RaoLRLakshmi Rao
- Vasudevan GeethaVGVasudevan Geetha
- B. V. TantryBTB. V. Tantry
- Hema KiniHKHema Kini
- Rajesh DharamsiRDRajesh Dharamsi
- C. Ganesh PaiCPC. Ganesh Pai
- Kapaettu SatyamoorthyKSKapaettu Satyamoorthy
Open Access
- 14 April 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-11
Abstract
The incidence of and mortality from colorectal cancers (CRC) can be reduced by early detection. Currently there is a lack of established markers to detect early neoplastic changes. We aimed to identify the copy number variations (CNVs) and the associated genes which could be potential markers for the detection of neoplasia in both ulcerative colitis-associated neoplasia (UC-CRN) and sporadic colorectal neoplasia (S-CRN). We employed array comparative genome hybridization (aCGH) to identify CNVs in tissue samples of UC nonprogressor, progressor and sporadic CRC. Select genes within these CNV regions as a panel of markers were validated using quantitative real time PCR (qRT-PCR) method along with the microsatellite instability (MSI) in an independent cohort of samples. Immunohistochemistry (IHC) analysis was also performed. Integrated analysis showed 10 overlapping CNV regions between UC-Progressor and S-CRN, with the 8q and 12p regions showing greater overlap. The qRT-PCR based panel of MYC, MYCN, CCND1, CCND2, EGFR and FNDC3A was successful in detecting neoplasia with an overall accuracy of 54 % in S-CRN compared to that of 29 % in UC neoplastic samples. IHC study showed that p53 and CCND1 were significantly overexpressed with an increasing frequency from pre-neoplastic to neoplastic stages. EGFR and AMACR were expressed only in the neoplastic conditions. CNVs that are common and unique to both UC-associated and sporadic colorectal neoplasm could be the key players driving carcinogenesis. Comparative analysis of CNVs provides testable driver aberrations but needs further evaluation in larger cohorts of samples. These markers may help in developing more effective neoplasia-detection strategies during screening and surveillance programs.Keywords
Funding Information
- Department of Biotechnology , Ministry of Science and Technology (BT/01/COE/06/02/07)
This publication has 47 references indexed in Scilit:
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Molecular alterations in colitis-associated colorectal neoplasia: Study from a low prevalence area using magnifying chromo colonoscopyJournal of Crohn's and Colitis, 2012
- Germline Copy Number Variations and Cancer PredispositionFuture Oncology, 2012
- Identification of a biomarker panel for colorectal cancer diagnosisBMC Cancer, 2012
- Germline copy number variation and cancer riskCurrent Opinion in Genetics & Development, 2010
- The Asia‐Pacific consensus on ulcerative colitisJournal of Gastroenterology and Hepatology, 2010
- Carcinogenesis in IBD: potential targets for the prevention of colorectal cancerNature Reviews Gastroenterology & Hepatology, 2009
- High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridizationCarcinogenesis, 2004
- Amplification of oncogenes in human cancer cellsBioEssays, 1998
- Overexpression and Amplification of c-myc during Progression of Human Colorectal CancerOncology, 1996